The Syndrome We Agreed to Call Bronchiolitis
- PMID: 30783666
- PMCID: PMC6581899
- DOI: 10.1093/infdis/jiz082
The Syndrome We Agreed to Call Bronchiolitis
Abstract
We are ignoring evidence suggesting that the diagnosis of bronchiolitis encompasses several diseases with distinct underlying mechanisms, considerable heterogeneity in treatment responses, and ultimately different therapeutic targets. Understanding this heterogeneity may be the only way to deliver appropriate, stratified treatments.
Keywords: bronchiolitis; endotypes; machine learning; respiratory syncytial virus.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America.
References
-
- Ralston SL, Lieberthal AS, Meissner HC, et al. . American Academy of Pediatrics Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics 2014; 134:e1474–502. - PubMed
-
- Murray CS, Woodcock A, Langley SJ, Morris J, Custovic A; IFWIN Study Team Secondary prevention of asthma by the use of inhaled fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study. Lancet 2006; 368:754–62. - PubMed
-
- Meissner HC. Viral bronchiolitis in children. N Engl J Med 2016; 374:62–72. - PubMed
-
- Scheltema NM, Nibbelke EE, Pouw J, et al. . Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial. Lancet Respir Med 2018; 6:257–64. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous